MORNING PEAK IN THE INCIDENCE OF MYOCARDIAL-INFARCTION - EXPERIENCE IN THE ISIS-2 TRIAL

Registros relacionados

• ISIS-2 - A LARGE RANDOMIZED TRIAL OF INTRAVENOUS STREPTOKINASE AND ORAL ASPIRIN IN ACUTE MYOCARDIAL-INFARCTION
  por: Collins, R, et al.
  Publicado em: (1989)
• ISIS COLLABORATIVE GROUP - RANDOMIZED TRIAL OF EARLY IV ATENOLOL IN MYOCARDIAL-INFARCTION - SUBSIDIARY ANALYSES
  por: Sleight, P, et al.
  Publicado em: (1986)
• ISIS-4 - REPLY
  por: Collins, R, et al.
  Publicado em: (1995)
• ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither
  por: Baigent, C, et al.
  Publicado em: (1998)
• Beta blockade during and after myocardial infarction: an overview of the randomized trials.
  por: Yusuf, S, et al.
  Publicado em: (1985)